- Filed
- May 22, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 21, 2026 | 593.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 611.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 454.71M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $24K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.57M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$2.06M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.61M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $3.55M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$24.76M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$654.87M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $93.09M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $677.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $96.44M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $677.36M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.23M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $85.62M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $22.49M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.72 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.72 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $16.1M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.8M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$440.31M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$18M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$15.66M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$2.8M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $445K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.43M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.88M |